GlassScriptPhysician profile
Kathryn A Ryan
NPI 1629418215
$4,753.18
in general payments reported to CMS, 2019-2025
45 companies · $727 in 2025
The $727 reported for 2025 was more than what 80% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $740 · 2020: $159 · 2021: $737 · 2022: $546 · 2023: $817 · 2024: $1,027 · 2025: $727.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,548 · Education: $23.04.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,547.74 |
| Education | $23.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $879.63 | 2021-2025 | Vraylar, Ubrelvy, Botox |
| Astrazeneca Pharmaceuticals LP | $525.83 | 2020-2025 | Breztri, Airsupra, Farxiga |
| Novo Nordisk INC | $492.24 | 2019-2025 | Wegovy, Ozempic, Rybelsus |
| Astellas Pharma US INC | $348.45 | 2021-2024 | Veozah, Myrbetriq |
| Glaxosmithkline, LLC. | $231.80 | 2019-2025 | Arexvy, Shingrix, Trelegy Ellipta |
| Lilly USA, LLC | $214.78 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Novartis Pharmaceuticals Corporation | $181.00 | 2019-2025 | |
| Allergan, INC. | $156.60 | 2019-2020 | |
| Pfizer INC. | $154.25 | 2019-2025 | |
| Exact Sciences Corporation | $102.91 | 2023-2025 | Cologuard Collection Kit |
| Sanofi-Aventis U.S. LLC | $96.50 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $93.62 | 2019-2022 | |
| Sumitomo Pharma America, INC. | $92.92 | 2023-2025 | Gemtesa |
| Janssen Pharmaceuticals, INC | $82.05 | 2019-2022 | |
| Amarin Pharma, INC. | $75.53 | 2019-2021 |
Show all 45 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kathryn Ryan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.